Journal of Bacteriology 2011-10-01

Whole genome sequence of the rifamycin B-producing strain Amycolatopsis mediterranei S699.

Mansi Verma, Jaspreet Kaur, Mukesh Kumar, Kirti Kumari, Anjali Saxena, Shailly Anand, Aeshna Nigam, Vydianathan Ravi, Saurabh Raghuvanshi, Paramjit Khurana, Akhilesh K Tyagi, Jitendra P Khurana, Rup Lal

Index: J. Bacteriol. 193(19) , 5562-3, (2011)

Full Text: HTML

Abstract

Amycolatopsis mediterranei S699 is an actinomycete that produces an important antibiotic, rifamycin B. Semisynthetic derivatives of rifamycin B are used for the treatment of tuberculosis, leprosy, and AIDS-related mycobacterial infections. Here, we report the complete genome sequence (10.2 Mb) of A. mediterranei S699, with 9,575 predicted coding sequences.

Related Compounds

Related Articles:

Evidence for a multidrug resistance-associated protein 1 (MRP1)-related transport system in cultured rat liver biliary epithelial cells.

1999-01-01

[Life Sci. 64(9) , 763-74, (1999)]

Phase shifts in the stoichiometry of rifamycin B fermentation and correlation with the trends in the parameters measured online.

2006-12-15

[J. Biotechnol. 127(1) , 115-28, (2006)]

Stereochemical assignment of intermediates in the rifamycin biosynthetic pathway by precursor-directed biosynthesis.

2005-08-17

[J. Am. Chem. Soc. 127(32) , 11202-3, (2005)]

Overproduction of rifamycin B by Amycolatopsis mediterranei and its relationship with the toxic effect of barbital on growth.

1998-01-01

[J. Antibiot. 51(1) , 58-63, (1998)]

Expression of the bacterial hemoglobin gene from Vitreoscilla stercoraria increases rifamycin B production in Amycolatopsis mediterranei.

2008-11-01

[J. Biosci. Bioeng. 106(5) , 493-7, (2008)]

More Articles...